These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12148892)

  • 1. Serum tryptase measurements in patients with myelodysplastic syndromes.
    Sperr WR; Stehberger B; Wimazal F; Baghestanian M; Schwartz LB; Kundi M; Semper H; Jordan JH; Chott A; Drach J; Jäger U; Geissler K; Greschniok A; Horny HP; Lechner K; Valent P
    Leuk Lymphoma; 2002 May; 43(5):1097-105. PubMed ID: 12148892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
    Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
    Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
    Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
    Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Myelodysplastic syndromes (MDS). Aspects of hematopathologic diagnosis].
    Schmitt-Graeff A; Mattern D; Köhler H; Hezel J; Lübbert M
    Pathologe; 2000 Jan; 21(1):1-15. PubMed ID: 10663664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum deoxythymidine kinase in myelodysplastic syndromes.
    Aul C; Gattermann N; Germing U; Winkelmann M; Heyll A; Runde V; Schneider W
    Cancer; 1994 Jan; 73(2):322-7. PubMed ID: 8293395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience.
    Yusuf U; Frangoul HA; Gooley TA; Woolfrey AE; Carpenter PA; Andrews RG; Deeg HJ; Appelbaum FR; Anasetti C; Storb R; Sanders JE
    Bone Marrow Transplant; 2004 Apr; 33(8):805-14. PubMed ID: 14755311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance between apoptosis and telomerase activity in myelodysplastic syndromes: possible role in ineffective hemopoiesis.
    Ohshima K; Karube K; Shimazaki K; Kamma H; Suzumiya J; Hamasaki M; Kikuchi M
    Leuk Lymphoma; 2003 Aug; 44(8):1339-46. PubMed ID: 12952227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome.
    de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E
    Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
    Foucar K; Langdon RM; Armitage JO; Olson DB; Carroll TJ
    Cancer; 1985 Aug; 56(3):553-61. PubMed ID: 3891071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary myelodysplastic syndromes: analysis of prognostic factors in 235 patients and proposals for an improved scoring system.
    Aul C; Gattermann N; Heyll A; Germing U; Derigs G; Schneider W
    Leukemia; 1992 Jan; 6(1):52-9. PubMed ID: 1736014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chymase expressing bone marrow mast cells in mastocytosis and myelodysplastic syndromes: an immunohistochemical and morphometric study.
    Horny HP; Greschniok A; Jordan JH; Menke DM; Valent P
    J Clin Pathol; 2003 Feb; 56(2):103-6. PubMed ID: 12560387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of soluble forms of ICAM and VCAM in patients with myelodysplastic syndromes and their prognostic significance.
    Passam FH; Tsirakis G; Boula A; Fragou A; Consolas I; Alegakis A; Kyriakou DS; Alexandrakis MG
    Clin Lab Haematol; 2004 Dec; 26(6):391-5. PubMed ID: 15595996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myelodysplastic syndromes--a population-based study on transformation and survival.
    Hörnsten P; Wahlin A; Rudolphi O; Nordenson I
    Acta Oncol; 1995; 34(4):473-8. PubMed ID: 7605654
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia.
    Sperr WR; Jordan JH; Baghestanian M; Kiener HP; Samorapoompichit P; Semper H; Hauswirth A; Schernthaner GH; Chott A; Natter S; Kraft D; Valenta R; Schwartz LB; Geissler K; Lechner K; Valent P
    Blood; 2001 Oct; 98(7):2200-9. PubMed ID: 11568008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fas/Apo-1 (CD95) expression and apoptosis in patients with myelodysplastic syndromes.
    Bouscary D; De Vos J; Guesnu M; Jondeau K; Viguier F; Melle J; Picard F; Dreyfus F; Fontenay-Roupie M
    Leukemia; 1997 Jun; 11(6):839-45. PubMed ID: 9177438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems.
    Rubio-Felix D; Giraldo P; Franco E; Gimeno J; Giralt M
    Hematol Oncol; 1995; 13(3):139-52. PubMed ID: 7622144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of apoptosis as a prognostic factor in myelodysplastic syndromes.
    Shimazaki K; Ohshima K; Suzumiya J; Kawasaki C; Kikuchi M
    Br J Haematol; 2000 Sep; 110(3):584-90. PubMed ID: 10997968
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic characteristics of 164 patients with myelodysplastic syndromes.
    Reza S; Dar S; Andric T; Qawi H; Mundle S; Shetty V; Venugopal P; Ali I; Lisak L; Raza A
    Leuk Lymphoma; 1999 Apr; 33(3-4):281-7. PubMed ID: 10221507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Karyotype in myelodysplastic syndromes: relations to morphology, clinical evolution, and survival.
    Bernasconi P; Alessandrino EP; Boni M; Bonfichi M; Morra E; Lazzarino M; Campagnoli C; Astori C
    Am J Hematol; 1994 Aug; 46(4):270-7. PubMed ID: 8037176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
    Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M
    Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.